Reactions 1680, p13 - 2 Dec 2017 Nephropathy: case report A 35-year-old man developed nephropathy after receiving treatment with aciclovir [acyclovir]. The man was hospitalised with fever refractory to antipyretics medications. He was diagnosed with viral encephalitis. He started receiving IV aciclovir 750 mg/8 hours. Three days later, his creatinine level abruptly increased to 6.9 mg/dL, accompanied with reduction in his consciousness. His aciclovir dose was adjusted to 750 mg/24 hours, after which he regained consciousness and his renal function tests normalised. Author comment: "The present case showed that high- dose intravenous acyclovir might induce nephropathy due to direct renal tubular toxicity, acute interstitial nephritis, and crystal nephropathy." Aziz MAE, et al. Acyclovir-induced nephropathy in an encephalitis patient: A case report and review of literature. CNS Spectrums 22: 88 abstr. 146, No. 1, Feb 2017. Available from: URL: http://doi.org/10.1017/S1092852916000900 [abstract] - Egypt 803284843 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera